Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Roche B (RO.S)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (CHF)	Price Target (CHF)	Rating
2021-09-02	408.60	375.00	Neutral
2021-09-08	405.20	390.00	Neutral
2021-10-21	394.40	400.00	Neutral
2022-02-11	378.40	380.00	Neutral
2022-04-19	409.40	380.00	Sell
2022-07-11	382.20	365.00	Neutral
2022-12-14	375.60	366.00	Neutral
2023-01-09	353.60	355.00	Neutral
2023-03-02	292.60	315.00	Neutral
2023-05-12	315.60	305.00	Neutral
2024-01-15	270.80	278.00	Neutral
2024-02-06	243.40	263.00	Neutral
2024-04-25	236.80	252.00	Neutral
2024-09-16	283.80	286.00	Neutral

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.